Diagnostic Testing and Emerging Technologies

Keeps You Up-to-Date on New Diagnostic Tests, Testing Trends and Opportunities, and Emerging Test Technologies

Quest Introduces Myeloma Test That Eliminates the Need for Bone Marrow Biopsies

By Ron Shinkman | Mar 26, 2026 | 1 min read

The flow cytometry assay costs a fraction of traditional invasive bone marrow testing

By Ron Shinkman | Mar 26, 2026 | 1 min read

The test offers a 76 percent sensitivity to detection of stage 1 and stage 2 pancreatic cancers

By Bree Foster, PhD | Mar 13, 2026 | 1 min read

A physics-based urine test shows early promise in detecting bladder cancer recurrence without invasive procedures

By Liv Gaskill, MSc | Jun 21, 2024 | 1 min read

Exploring the opportunities, challenges, and current research in lab-based testing for mental health disorders

By Michael Schubert, PhD | Jun 21, 2024 | 1 min read

Laboratorian and workplace wellness expert discusses mental health challenges in the lab—and how to foster safety and support

By Michael Schubert, PhD | Jun 21, 2024 | 1 min read

What lab tests currently inform mental health care—and how might the testing landscape change as our understanding and technologies evolve?

By Oscelle Boye, MBiomed | Jun 21, 2024 | 1 min read

Workplace bullying is a serious concern in the clinical lab. How can it be addressed?

By Rachel Muenz | May 30, 2024 | 1 min read

Andreas Jeromin, PhD, chief scientific officer at ALZPath, discusses the current landscape of blood-based AD tests and their future.

By Rachel Muenz | May 30, 2024 | 1 min read

Alison Green, PhD, head of laboratory sciences at Scottish Brain Sciences, discusses recent developments in AD blood tests

By Michael Schubert, PhD | May 27, 2024 | 1 min read

A new capillary blood collection system, the BD MiniDraw™, can improve the testing experience for both labs and patients

By Oscelle Boye, MBiomed | May 27, 2024 | 1 min read

Examining what led to record low BB/TM ABPath certification examination pass rates in 2022

By Ron Shinkman | May 27, 2024 | 1 min read

Publishing peer-reviewed studies to tout the economic benefits of medical devices is fairly commonplace, but rare for a laboratory company

By Michael Schubert, PhD | May 24, 2024 | 1 min read

Multicancer early detection tests—and their promise of comprehensive, minimally invasive screening—are catching the eye of labs and lawmakers